NovelStem International NSTM
OTC NSTM
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovelStem International (NSTM) Asset Writedowns and Impairment (2024)

Updated

NovelStem International (NSTM) reported Asset Writedowns and Impairment of $1.63 million for Q3 2024.

Analysis

NovelStem International (NSTM) Asset Writedowns and Impairment (2024) Analysis & Trends

For FY2012, NovelStem International posted Asset Writedowns and Impairment of $3.6 million, down 24.9% from FY2011.

  • Asset Writedowns and Impairment has a three-year compound annual growth rate of -10.4% (FY2009 to FY2012).
  • By year, Asset Writedowns and Impairment came in at $4.8 million in FY2011 and $5 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 NovelStem International 493,324.54 346,279.54 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.63 Mn
API Access

NovelStem International Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=NSTM&period=max&api_key=YOUR_API_KEY